Skip to content
Premier Research

Premier Research

  • Capabilities
    • Column
      • Clinical Research & Development
      • Product Development & Regulatory Consulting
      • Nonclinical & Early Development
      • Real-World & Late Phase
      • Functional Service Provider (FSP)
      • Remarque
  • Expertise
    • Column
      • Oncology & Hematology
      • Rare Disease
      • Cell & Gene Therapy
      • Pediatrics
    • Column
      • Neuroscience
      • Analgesia
      • Dermatology
      • Women’s Health
    • Column
      • 505(b)(2) Pathway
      • MedTech
      • Internal Medicine & Immunology
  • Insights
    • Premier Perspectives Blog
    • Resource Center
  • About Us
    • Column
      • Our Approach
      • Leadership
      • Corporate Responsibility
    • Column
      • News
      • Events
      • Locations
      • Contact Us
  • Careers
  • Investigators
  • Request Information

Premier Perspectives Blog

The blog for insider insights in clinical development
Clinical Development

Smarter Approaches to Outsourcing Pharmacovigilance in Clinical Trials: Protecting Patient Safety

Read more
By Lee McGuinness
April 29, 2025

Featured Posts

Nonclinical

FDA Eliminates Animal Testing: Impact on Biotechs

Read more
By William Salminen
April 14, 2025
Clinical Development

Amplifying Patient Voices: The Impact of Advocacy Groups in Clinical Trials

Read more
By Sarah Cross
April 8, 2025

Featured Podcasts

Conversations with Premier’s subject matter experts

PREMIER VOICES #15

Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients

Listen Now
PREMIER VOICES #11

Statistical Considerations in the Wake of COVID-19

Listen Now
PREMIER VOICES #10

COVID-19 Update – How the FDA’s Emergency Use Authorization Can Help Develop Therapies Faster

Listen Now
PREMIER VOICES #15

Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients

Listen Now
PREMIER VOICES #11

Statistical Considerations in the Wake of COVID-19

Listen Now
PREMIER VOICES #10

COVID-19 Update – How the FDA’s Emergency Use Authorization Can Help Develop Therapies Faster

Listen Now
Connect With Us

Capabilities

  • Clinical Research & Development
  • Product Development & Regulatory Consulting
  • Nonclinical & Early Development
  • Real-World & Late Phase
  • Functional Service Provider (FSP)
  • Remarque

Expertise

  • Oncology & Hematology
  • Rare Disease
  • Cell & Gene Therapy
  • Pediatrics
  • Neuroscience
  • Analgesia
  • Dermatology
  • Women's Health
  • 505(b)(2) Pathway
  • MedTech
  • Internal Medicine & Immunology

Insights

  • Premier Perspectives Blog
  • Resource Center

About Us

  • Our Approach
  • Leadership
  • Corporate Responsibility

Connect

  • News
  • Events
  • Locations
  • Investigators
  • Careers
  • Contact Us
Connect With Us
  • Corporate Policy
  • Privacy
  • Cookie Policy
©2025 Premier Research